Eleanor Elizabeth Russell-Goldman, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sweat Gland Neoplasms | 5 | 2024 | 117 | 3.490 |
Why?
|
Skin Neoplasms | 14 | 2024 | 5797 | 2.000 |
Why?
|
Hair Diseases | 3 | 2023 | 72 | 1.780 |
Why?
|
Carcinoma, Basal Cell | 3 | 2023 | 559 | 1.600 |
Why?
|
Hamartoma Syndrome, Multiple | 2 | 2023 | 114 | 1.540 |
Why?
|
Epidermodysplasia Verruciformis | 1 | 2024 | 22 | 0.930 |
Why?
|
Muir-Torre Syndrome | 1 | 2023 | 12 | 0.920 |
Why?
|
Adenocarcinoma, Sebaceous | 1 | 2023 | 21 | 0.900 |
Why?
|
Sebaceous Gland Neoplasms | 1 | 2023 | 40 | 0.890 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2023 | 63 | 0.860 |
Why?
|
Immunohistochemistry | 7 | 2024 | 11064 | 0.840 |
Why?
|
Adenoma, Sweat Gland | 1 | 2022 | 17 | 0.840 |
Why?
|
Acrospiroma | 1 | 2022 | 12 | 0.830 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2023 | 4024 | 0.810 |
Why?
|
Mucin-2 | 1 | 2022 | 50 | 0.800 |
Why?
|
Fibroma | 1 | 2023 | 190 | 0.800 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2022 | 89 | 0.790 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2021 | 68 | 0.750 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2023 | 218 | 0.750 |
Why?
|
Nevus | 1 | 2023 | 205 | 0.740 |
Why?
|
Eccrine Porocarcinoma | 1 | 2020 | 18 | 0.740 |
Why?
|
Neoplasms, Fibroepithelial | 1 | 2020 | 8 | 0.730 |
Why?
|
Sarcoma, Kaposi | 1 | 2024 | 376 | 0.730 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2022 | 194 | 0.670 |
Why?
|
Adenoma, Pleomorphic | 1 | 2020 | 75 | 0.670 |
Why?
|
Precancerous Conditions | 2 | 2023 | 978 | 0.650 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2020 | 73 | 0.650 |
Why?
|
Skin Aging | 1 | 2020 | 141 | 0.630 |
Why?
|
Antibodies, Antinuclear | 1 | 2020 | 344 | 0.620 |
Why?
|
Lymphoma, B-Cell | 1 | 2023 | 935 | 0.550 |
Why?
|
Nuclear Proteins | 5 | 2022 | 5793 | 0.530 |
Why?
|
Hodgkin Disease | 1 | 2023 | 1381 | 0.510 |
Why?
|
Neuroblastoma | 1 | 2022 | 1252 | 0.460 |
Why?
|
Repressor Proteins | 2 | 2022 | 2978 | 0.450 |
Why?
|
Biopsy, Fine-Needle | 1 | 2018 | 1111 | 0.440 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 2 | 2024 | 77 | 0.430 |
Why?
|
Zebrafish Proteins | 1 | 2018 | 1006 | 0.400 |
Why?
|
Klebsiella Infections | 1 | 2013 | 147 | 0.400 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1600 | 0.400 |
Why?
|
Melanoma | 4 | 2023 | 5695 | 0.380 |
Why?
|
Klebsiella pneumoniae | 1 | 2013 | 255 | 0.380 |
Why?
|
beta-Lactamases | 1 | 2013 | 304 | 0.380 |
Why?
|
Sarcoma | 1 | 2022 | 1786 | 0.380 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2895 | 0.350 |
Why?
|
Mutation | 8 | 2023 | 29950 | 0.340 |
Why?
|
Escherichia coli Infections | 1 | 2013 | 524 | 0.330 |
Why?
|
Piperazines | 1 | 2020 | 2520 | 0.330 |
Why?
|
Transcription Factors | 4 | 2022 | 12100 | 0.330 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2414 | 0.330 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3613 | 0.310 |
Why?
|
Pyridines | 1 | 2020 | 2877 | 0.300 |
Why?
|
Gene Rearrangement | 2 | 2023 | 1122 | 0.290 |
Why?
|
PTEN Phosphohydrolase | 2 | 2023 | 1115 | 0.270 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 9590 | 0.270 |
Why?
|
Lung Neoplasms | 3 | 2019 | 13249 | 0.250 |
Why?
|
Microphthalmia-Associated Transcription Factor | 2 | 2024 | 259 | 0.240 |
Why?
|
Cross Infection | 1 | 2013 | 1434 | 0.230 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 5248 | 0.220 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2023 | 184 | 0.210 |
Why?
|
Humans | 34 | 2024 | 760261 | 0.210 |
Why?
|
Nevus, Blue | 1 | 2022 | 43 | 0.200 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2023 | 180 | 0.200 |
Why?
|
Trans-Activators | 2 | 2022 | 2861 | 0.200 |
Why?
|
Eczema | 1 | 2023 | 245 | 0.190 |
Why?
|
Escherichia coli | 1 | 2013 | 4223 | 0.190 |
Why?
|
Gene Fusion | 1 | 2023 | 354 | 0.180 |
Why?
|
Drug Eruptions | 1 | 2023 | 335 | 0.180 |
Why?
|
Facial Transplantation | 1 | 2023 | 221 | 0.180 |
Why?
|
Scalp | 1 | 2022 | 389 | 0.170 |
Why?
|
Uveal Neoplasms | 1 | 2022 | 339 | 0.170 |
Why?
|
Hair Follicle | 1 | 2021 | 211 | 0.160 |
Why?
|
Sarcoma, Small Cell | 1 | 2018 | 17 | 0.160 |
Why?
|
Exanthema | 1 | 2023 | 504 | 0.160 |
Why?
|
Papillomaviridae | 1 | 2024 | 1117 | 0.150 |
Why?
|
beta Catenin | 1 | 2023 | 1043 | 0.150 |
Why?
|
Receptors, Androgen | 1 | 2023 | 1075 | 0.140 |
Why?
|
Mycobacterium tuberculosis | 1 | 2008 | 1905 | 0.140 |
Why?
|
DNA Helicases | 1 | 2022 | 854 | 0.140 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13629 | 0.140 |
Why?
|
Translocation, Genetic | 1 | 2022 | 1388 | 0.140 |
Why?
|
Central Nervous System Cysts | 1 | 2016 | 56 | 0.140 |
Why?
|
Carcinoma, Small Cell | 1 | 2018 | 416 | 0.130 |
Why?
|
Dermatomyositis | 1 | 2019 | 256 | 0.130 |
Why?
|
Diagnosis, Differential | 3 | 2022 | 12968 | 0.130 |
Why?
|
Retrospective Studies | 7 | 2023 | 80301 | 0.130 |
Why?
|
Immunity, Innate | 1 | 2008 | 3046 | 0.130 |
Why?
|
Dermoid Cyst | 1 | 2016 | 92 | 0.130 |
Why?
|
Antigens, Neoplasm | 1 | 2023 | 1999 | 0.130 |
Why?
|
Leg Ulcer | 1 | 2015 | 69 | 0.130 |
Why?
|
Psoriasis | 1 | 2023 | 939 | 0.130 |
Why?
|
Tuberculosis | 1 | 2008 | 2003 | 0.120 |
Why?
|
Bacterial Proteins | 1 | 2008 | 3822 | 0.120 |
Why?
|
Aged | 9 | 2024 | 168995 | 0.120 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2018 | 321 | 0.120 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1591 | 0.120 |
Why?
|
Craniopharyngioma | 1 | 2016 | 277 | 0.110 |
Why?
|
Thrombin | 1 | 2016 | 593 | 0.110 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2013 | 144 | 0.110 |
Why?
|
Chromosome Aberrations | 1 | 2020 | 1767 | 0.110 |
Why?
|
Cytokines | 1 | 2008 | 7345 | 0.110 |
Why?
|
Exons | 1 | 2019 | 2391 | 0.110 |
Why?
|
Molecular Typing | 1 | 2013 | 116 | 0.110 |
Why?
|
Female | 14 | 2024 | 391011 | 0.100 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2020 | 1094 | 0.100 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4109 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 649 | 0.100 |
Why?
|
Observer Variation | 1 | 2018 | 2596 | 0.100 |
Why?
|
Biopsy | 1 | 2023 | 6775 | 0.100 |
Why?
|
Molecular Epidemiology | 1 | 2013 | 469 | 0.090 |
Why?
|
Aged, 80 and over | 6 | 2024 | 58947 | 0.090 |
Why?
|
Protozoan Proteins | 1 | 2016 | 838 | 0.090 |
Why?
|
Male | 11 | 2024 | 359413 | 0.090 |
Why?
|
Middle Aged | 8 | 2024 | 220175 | 0.090 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4891 | 0.090 |
Why?
|
Adult | 7 | 2024 | 219847 | 0.090 |
Why?
|
Endothelium, Vascular | 1 | 2022 | 4437 | 0.090 |
Why?
|
Cell Adhesion | 1 | 2016 | 3096 | 0.090 |
Why?
|
Skin | 1 | 2023 | 4468 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3618 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2013 | 1166 | 0.080 |
Why?
|
Pituitary Neoplasms | 1 | 2016 | 1313 | 0.080 |
Why?
|
Germ-Free Life | 1 | 2008 | 187 | 0.080 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1447 | 0.070 |
Why?
|
Blotting, Southern | 1 | 2008 | 778 | 0.070 |
Why?
|
Genetic Complementation Test | 1 | 2008 | 555 | 0.070 |
Why?
|
Plasmodium falciparum | 1 | 2016 | 1741 | 0.070 |
Why?
|
Prognosis | 2 | 2023 | 29636 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4317 | 0.060 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2024 | 102 | 0.060 |
Why?
|
DNA, Bacterial | 1 | 2008 | 1455 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14656 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2020 | 21065 | 0.050 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2022 | 102 | 0.050 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2023 | 317 | 0.050 |
Why?
|
Gene Deletion | 1 | 2008 | 2668 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20048 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 2022 | 652 | 0.040 |
Why?
|
Necrosis | 1 | 2023 | 1612 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1158 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2008 | 3207 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2016 | 18968 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2023 | 2500 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 4357 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2020 | 538 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2023 | 3618 | 0.030 |
Why?
|
Survival Analysis | 1 | 2008 | 10185 | 0.030 |
Why?
|
Up-Regulation | 1 | 2024 | 4127 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2020 | 1633 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1890 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22066 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2022 | 1843 | 0.030 |
Why?
|
Macrophages | 1 | 2008 | 5745 | 0.030 |
Why?
|
Animals | 2 | 2020 | 167940 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2008 | 14396 | 0.030 |
Why?
|
Graft Survival | 1 | 2023 | 3793 | 0.030 |
Why?
|
Young Adult | 3 | 2024 | 58673 | 0.020 |
Why?
|
Leg | 1 | 2015 | 1091 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 22025 | 0.020 |
Why?
|
Graft Rejection | 1 | 2023 | 4423 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3810 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11141 | 0.020 |
Why?
|
Erythrocytes | 1 | 2016 | 2415 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9196 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16543 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2016 | 3537 | 0.010 |
Why?
|
Mice | 1 | 2008 | 81216 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41317 | 0.010 |
Why?
|
Chronic Disease | 1 | 2015 | 9283 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 17766 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 87747 | 0.010 |
Why?
|